medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2013, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2013; 29 (1)

Cutaneous Rosai-Dorfman disease: a propos of a case

Cruz-Camejo Y, Burgos-Aragüez D, Flores-Veja Y, Cáceres-Lavernia HH, Jiménez-Galainena J, Curbelo-Heredia I

Language: Spanish
References: 31
Page: 90-98
PDF size: 277.16 Kb.


ABSTRACT

A 50 year-old patient with a painless round tumoral lesion on inguinal region with progressive growth and formation of an eritematous plaque with areas of pigmentation, infiltration of deep tissues and apparition of other lesions with tumoral aspect is described. The anatomopathological study showed a hystiocitic infiltrate with linfohystiofagocitosis phenomenon (Emperipolesis) and the immunohystochemical made evident positive for Vimentine, S-100, CD68 and Lisozime. The available scientific evidence of the international literature was reviewed to determine the most frequent clinical manifestations of this disease, as well as most updated means of diagnosis employed and the treatment of this disease. It is important to consider the cutaneous Rosai-Dorfman disease as one of the possible diagnosis so a profound study of the biopsy is essential, as well as the immunohystochemical studies due to the mildness and good prognosis of this disease.


REFERENCES

  1. Destombes P. Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali. Bull Soc Pathol Exot Filiales. 1965 Nov-Dec;58(6):1169-75.

  2. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol. 1969 Jan;87(1):63-70.

  3. Lu CI, Kuo TT, Wong WR, Hong HS. Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan. J Am Acad Dermatol. 2004 Dec;51(6):931-9.

  4. Carrington PR, Reed RJ, Sanusi ID, Fowler M. Extranodal Rosai-Dorfman disease (RDD) of the skin. Int J Dermatol. 1998 Apr;37(4):271-4.

  5. Cabrera HN, Fernández Venegas MS, Verdejo G, Casas JG. Enfermedad de Rosai-Dorfman: forma clínica acneiforme. Dermatol Argent. 2010;16 (Supl 2):23-6.

  6. Chu P, LeBoit PE. Histologic features of cutaneous sinus histiocytosis (Rosai-Dorfman disease): study of cases both with and without systemic involvement. J Cutan Pathol. 1992;19:201-6.

  7. Molina-Garrido MJ, Guillén-Ponce C. Extranodal rosai-dorfman disease with cutaneous and periodontal involvement: a rare presentation. Case Rep Oncol. 2011 Feb;4(1):96-100.

  8. Thawerani H, Sánchez RL, Rosai J, Dorfman RF. The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch Dermatol. 1978 Feb;114(2):191-7.

  9. Pitamber HV, Grayson W. Five cases of cutaneous Rosai-Dorfman disease. Clin Exp Dermatol. 2003 Jan;28(1):1721.

  10. Kroumpouzos G, Demierre MF. Cutaneous Rosai-Dorfman disease: histopathological presentation as inflammatory pseudotumor. A literature review. Acta Derm Venereol. 2002;82(4):292-6.

  11. Kusutani N, Tamiya H, Tsuruta D, Mizuno N, Sowa J, Kaida M, et al. Apoptosis of neutrophils resulting after emperipolesis in cutaneous Rosai-Dorfman disease: a new ultrastructural finding. J Cutan Pathol. 2011 Jan;38(6):529-31.

  12. Gupta P, Babyn P. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): a clinicoradiological profile of three cases including two with skeletal disease. Pediatr Radiol. 2008 Jul;38(7):721-8.

  13. Kala C, Agarwal A, Kala S. Extranodal manifestation of Rosai-Dorfman disease with bilateral ocular involvement. J Cytol. 2011 Jul;28(3):131-3.

  14. Rubenstein MA, Farnsworth NN, Pielop JA, Orengo IF, Curry JL, Drucker CR, et al. Cutaneous Rosai-Dorfman disease. Dermatol Online J. 2006 Jan;12(1):8.

  15. Landim FM, Rios Hde O, Costa CO, Feitosa RG, Rocha Filho FD, Costa AA. Cutaneous Rosai-Dorfman disease. An Bras Dermatol. 2009 Jul;84(3):275-8.

  16. Hindermann W, Katenkamp D. Extranodal Rosai Dorfman disease (sinus histiocytosis with massive lymphadenopathy). Report of 5 cases. Pathologe. 2004 May;25(3):222-8.

  17. Bassis AV, Fairley JA, Ameln RT, Swick BL. Cutaneous Rosai-Dorfman disease following pneumococcal vaccination. J Am Acad Dermatol. 2011 Oct;65(4):890-2.

  18. Shi XY, Ma DL, Fang K. Cutaneous Rosai-Dorfman disease presenting as a granulomatous rosacea-like rashs. Chin Med J (Engl). 2011 Mar;124(5):793-4.

  19. Pitamber HV, Grayson W. Five cases of cutaneous Rosai-Dorfman disease. Clin Dermatol. 2003 Jan;28(1):17-21.

  20. Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, Fletcher CD, et al. Cutaneous Rosai-Dorfman disease is a distinct clinical entity. Am J Dermatopathol. 2002 Oct;24(5):385-91.

  21. Foucar E, Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. An analysis of 14 deaths occurring in a patient registry. Cancer. 1984 Nov;54(9):1834-40.

  22. Beltrán G, Navarro F, Meza B, Bravo F, Santos R. Enfermedad de Rosai-Dorfman cutánea: tratamiento con nitrógeno líquido. Folia Dermatol Perú. 2004;14(3):198-200.

  23. Pérez A, Rodríguez M, Febrer I, Aliaga A. Sinus histiocytosis confined to the skin: case report and review of the literature. Am J Dermatopathol. 1995 Aug;17(4):384-8.

  24. Annessi G, Giannetti A. Purely cutaneous Rosai-Dorfman disease. Br J Dermatol. 1996;134:749-53.

  25. Quaglino P, Tomasini C, Novelly M, Colonna S, Bernengo MG. Immunohistologic findings and adhesion molecule pattern in primary pure cutaneous Rosai-Dorfman disease with xanthomatous features. Am J Dermatopathol. 1998 Aug;20(4):393-8.

  26. Quispetira J, Moisés C, Paredes A, Sánchez G, Pacheco M, Carbajal T. Enfermedad de Rosai-Dorfman cutánea: reporte de caso y revisión de la literatura. Folia Dermatol Peru. 2009;20(2):91-4.

  27. Chang HS, Son SJ, Cho KH, Lee JH. Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease. Clin Exp Dermatol. 2011 Jun;36(4):420-2.

  28. Fening K, Bechtel M, Peters S, Zirwas M, Darabi K. Cutaneous rosai-dorfman disease persisting after surgical excision: report of a case treated with acitretin. J Clin Aesthet Dermatol. 2010 Sept;3(9):34-6.

  29. Fumerton R, Ball N, Zhou Y. Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy. Cutis. 2011 Jun;87(6):296-9.

  30. Pulsoni A, Villivà N, Cavalieri E, Falcucci P, La Verde G, Matera R, et al. Continuous low dose of melphalan and prednisone in patients with multiple myeloma of very old age or severe associated disease. Drugs Aging. 2002;19(12):947-53.

  31. Palomera L, Domingo JM, Soria J, Gutiérrez M. Supervivencia prolongada en un paciente con enfermedad de Rosai-Dorfman de curso agresivo tratado con interferón alfa. Med Clin (Barc). 2001 Jun;116(20):797-8.




2020     |     www.medigraphic.com